US Patent 8703203 Oral dosage form of deferasirox
Patent 8703203 was granted and assigned to Ratiopharm on April, 2014 by the United States Patent and Trademark Office.
All edits
Edits on 1 Dec, 2023
Golden AI
Edits made to:
Article (+337 characters)
Article
Patent abstract
The invention relates to an oral dosage form containing deferasirox, binder, disintegrant and optionally wicking agent, wherein the introduction of the dosage form into water leads to a suspension wherein the suspended particles have an average particle size (D50) of 20 μm to 120 μm, and also to a method of producing it.
Edits on 25 Sep, 2023
Golden AI
Edits made to:
Infobox (+2 properties)
Infobox
Patent Inventor Names
Jana Paetz0
Katrin Rimkus0
Edits on 22 Jul, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 14 Jul, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 08703203 Oral dosage form of deferasirox US Patent 8703203 Oral dosage form of deferasirox
Infobox
Patent Number
087032030
Patent Number
87032030
Edits on 27 Apr, 2023
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
087032030
Date of Patent
April 22, 2014
0Patent Application Number
138077380
Date Filed
July 7, 2011
0Official Website
Patent Primary Examiner
Edits on 19 May, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 22 Dec, 2021
Golden AI
Edits made to:
Infobox (+8 properties)
US Patent 08703203 Oral dosage form of deferasirox
Infobox
Is a
Current assignee
Patent jurisdiction
Patent number
08703203
Date of patent
April 22, 2014
Patent application number
13807738
Date Filed
July 7, 2011
Patent primary examiner
Find more entities like US Patent 8703203 Oral dosage form of deferasirox
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.